ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2025

Reply to "Reconsidering dopaminergic modulation in Alzheimer's disease: A case for levodopa/carbidopa as a disease-modifying agent".

Zsuzsa Sárkány et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.